152 results
8-K
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
5 Jan 24
Other Events
5:50pm
of factors including coverage and reimbursement levels from governmental authorities and health insurers as well as market acceptance by healthcare providers
8-K
EX-10.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
17 Oct 23
Entry into a Material Definitive Agreement
7:24pm
form regulated pursuant to any Environmental Law.
“Healthcare Laws” means, collectively, all local, state, federal, national, and supranational … , and foreign healthcare laws, manual provisions, policies and administrative guidance relating to the regulation of the Loan Parties including, without
S-3ASR
EX-1.2
9s8o4
30 Sep 22
Automatic shelf registration
4:17pm
8-K
EX-99.1
izlp7fakhwx
29 Jun 22
Ligand Pharmaceuticals Appoints Jason Haas to its Board of Directors
5:17pm
8-K
qchdjij3l93eu4f5es1p
29 Jun 22
Ligand Pharmaceuticals Appoints Jason Haas to its Board of Directors
5:17pm
425
EX-99.1
5i5ds4 hs79
21 Jun 22
Business combination disclosure
8:00am
8-K
EX-99.1
1aogh
21 Jun 22
Regulation FD Disclosure
6:19am
425
saiewy
24 Mar 22
Business combination disclosure
9:09am
8-K
EX-2.1
2bzcgq qhw2g9d
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
425
EX-99.2
z3r6n
23 Mar 22
Business combination disclosure
5:29pm
425
EX-99.1
aa7qauyxc7k3
23 Mar 22
Business combination disclosure
5:29pm
425
EX-99.3
okhtnxykn77uuuvmd4hp
23 Mar 22
Business combination disclosure
5:29pm
8-K
EX-99.3
k2nsuvu
23 Mar 22
Ligand to Spin-Off its OmniAb Business Through Merger with Avista Public Acquisition Corp. II
5:25pm
8-K
EX-99.1
mvocn3p
23 Mar 22
Ligand to Spin-Off its OmniAb Business Through Merger with Avista Public Acquisition Corp. II
5:25pm